Abstract
Chronic inflammatory diseases represent an increasing medical burden, yet neither tools to predict the individual disease course nor causal cures are at hand. We discuss opportunities for systems medicine to derive precise, individualized disease models and outline the European consortium SYSCID as part of the roadmap to clinical practice.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Arthritis, Rheumatoid / diagnosis
-
Arthritis, Rheumatoid / genetics
-
Arthritis, Rheumatoid / pathology
-
Diabetes Mellitus, Type 1 / diagnosis
-
Diabetes Mellitus, Type 1 / genetics
-
Diabetes Mellitus, Type 1 / pathology
-
Europe
-
Humans
-
Inflammation* / diagnosis
-
Inflammation* / genetics
-
Inflammation* / pathology
-
Inflammation* / therapy
-
Inflammatory Bowel Diseases / diagnosis
-
Inflammatory Bowel Diseases / genetics
-
Inflammatory Bowel Diseases / pathology
-
Lupus Erythematosus, Systemic / diagnosis
-
Lupus Erythematosus, Systemic / genetics
-
Lupus Erythematosus, Systemic / pathology
-
Psoriasis / diagnosis
-
Psoriasis / genetics
-
Psoriasis / pathology
-
Systems Analysis*